---
title: Metoclopramide + Paracetamol
description: >-
  Metoclopramide + Paracetamol is prescribed for the relief of symptoms
  associated with migraine, including nausea, vomiting, and headache. 
  Paracetamol is a non-opioid analgesic, while metoclopramide is an antiemetic
  and prokinetic agent.  Therefore, this combination targets both the pain and
  the ...
is_banned: false
lastModified: '2025-09-22T17:22:09.570Z'
faqs:
  - q: >-
      What is the recommended dosage for Metoclopramide + Paracetamol?**

      **A:** The standard adult dosage is two tablets initially, then one or two
      every four hours as needed, not exceeding six tablets in 24 hours.
    a: >-
      A:** The standard adult dosage is two tablets initially, then one or two
      every four hours as needed, not exceeding six tablets in 24 hours.
  - q: >-
      What are the common side effects?**

      **A:** Common side effects include drowsiness, dizziness, diarrhea, and
      restlessness.
    a: >-
      A:** Common side effects include drowsiness, dizziness, diarrhea, and
      restlessness.
  - q: >-
      Is this combination safe in pregnancy?**

      **A:** Although generally considered safe, it should be used with caution
      during pregnancy, after careful assessment of the benefit-risk ratio.
    a: >-
      A:** Although generally considered safe, it should be used with caution
      during pregnancy, after careful assessment of the benefit-risk ratio.
  - q: >-
      Are there any serious side effects to be aware of?**

      **A:**  Rare but serious side effects include extrapyramidal reactions
      (dystonia, akathisia, tardive dyskinesia), neuroleptic malignant syndrome,
      and hypersensitivity reactions.
    a: >-
      A:**  Rare but serious side effects include extrapyramidal reactions
      (dystonia, akathisia, tardive dyskinesia), neuroleptic malignant syndrome,
      and hypersensitivity reactions.
  - q: >-
      Can this medication be used in children?**

      **A:**  It's generally not recommended for children under 12. Consult
      specialized pediatric resources for specific cases.
    a: >-
      A:**  It's generally not recommended for children under 12. Consult
      specialized pediatric resources for specific cases.
  - q: >-
      What are the contraindications for this combination?**

      **A:** Contraindications include hypersensitivity, GI obstruction,
      hemorrhage, perforation, and pheochromocytoma.
    a: >-
      A:** Contraindications include hypersensitivity, GI obstruction,
      hemorrhage, perforation, and pheochromocytoma.
  - q: >-
      What should I monitor patients for when prescribing this medication?**

      **A:** Monitor patients for extrapyramidal symptoms, particularly in
      children, young adults, and patients receiving higher doses.
    a: >-
      A:** Monitor patients for extrapyramidal symptoms, particularly in
      children, young adults, and patients receiving higher doses.
  - q: >-
      How does metoclopramide work in migraine?**

      **A:**  Metoclopramide is thought to relieve migraine-associated nausea
      and vomiting by blocking dopamine receptors in the chemoreceptor trigger
      zone and enhancing gastric emptying.  It also has some analgesic
      properties through its effects on serotonin receptors.
    a: >-
      A:**  Metoclopramide is thought to relieve migraine-associated nausea and
      vomiting by blocking dopamine receptors in the chemoreceptor trigger zone
      and enhancing gastric emptying.  It also has some analgesic properties
      through its effects on serotonin receptors.
  - q: >-
      What are the alternatives if this combination is not suitable?**

      **A:**  Alternative treatments for migraine might include other
      antiemetics (e.g., ondansetron), NSAIDs or triptans for pain, or other
      combination therapies.  The choice depends on the specific patient's
      presentation and medical history.
    a: >-
      A:**  Alternative treatments for migraine might include other antiemetics
      (e.g., ondansetron), NSAIDs or triptans for pain, or other combination
      therapies.  The choice depends on the specific patient's presentation and
      medical history.
---
## **Usage**

Metoclopramide + Paracetamol is prescribed for the relief of symptoms associated with migraine, including nausea, vomiting, and headache.  Paracetamol is a non-opioid analgesic, while metoclopramide is an antiemetic and prokinetic agent.  Therefore, this combination targets both the pain and the gastrointestinal symptoms associated with migraine.

## **Alternate Names**

This combination medication may not have a universally recognized International Nonproprietary Name (INN).  However, it is marketed under various brand names, some of which include Anagraine® and Paramax®. Regional variations in the name may exist.  Refer to local formularies for specific brand names and formulations.

## **How It Works**

**Paracetamol:**
* **Pharmacodynamics:** Paracetamol exerts its analgesic and antipyretic effects through central inhibition of prostaglandin synthesis, primarily in the hypothalamus.  Its exact mechanism remains partially elucidated but is thought to involve interactions with the endocannabinoid system and other pathways.  It has weak peripheral anti-inflammatory activity.
* **Pharmacokinetics:**  Paracetamol is rapidly absorbed from the gastrointestinal tract, reaching peak plasma concentrations within 30-60 minutes.  It is extensively metabolized in the liver via glucuronidation, sulfation, and oxidation (mediated by CYP enzymes, particularly CYP2E1).  The metabolites are primarily excreted renally.

**Metoclopramide:**
* **Pharmacodynamics:** Metoclopramide is a dopamine D2 receptor antagonist.  It also has serotonin 5-HT3 receptor antagonist and 5-HT4 receptor agonist properties.  It enhances acetylcholine release in the enteric nervous system, increasing gastrointestinal motility.  Its antiemetic action is attributed to both central and peripheral mechanisms, including blockade of dopamine receptors in the chemoreceptor trigger zone.
* **Pharmacokinetics:** Metoclopramide is rapidly absorbed following oral administration. It undergoes hepatic metabolism primarily through conjugation and is excreted mainly in the urine, with a small portion eliminated in bile.

## **Dosage**

### **Standard Dosage**

#### **Adults:**

The standard adult dosage for migraine is typically two tablets (containing 500 mg paracetamol and 5 mg metoclopramide each) initially, followed by one or two tablets every four hours as needed, not to exceed six tablets in a 24-hour period.


#### **Children:**

This combination is generally not recommended for children under 12 years of age. Consult specialized pediatric resources for dosing recommendations in exceptional circumstances and consider alternative medications.


#### **Special Cases:**

* **Elderly Patients:**  Start with a lower dose and monitor for adverse effects.  Dose adjustments may be necessary based on renal and hepatic function.
* **Patients with Renal Impairment:** Dose reduction is recommended in patients with moderate to severe renal impairment. Consult specific dosing guidelines and consider creatinine clearance.
* **Patients with Hepatic Dysfunction:** Dose reduction is necessary in patients with moderate to severe hepatic impairment.
* **Patients with Comorbid Conditions:**  Exercise caution in patients with a history of depression, Parkinson's disease, epilepsy, or other neurological disorders.


### **Clinical Use Cases**

This combination is not typically used in clinical settings like intubation, surgical procedures, mechanical ventilation, ICU, or emergency situations.  Metoclopramide alone may be used in some of these contexts, but the dosages and administration routes are different and determined by the specific clinical situation.


### **Dosage Adjustments**

Dosage adjustments are needed based on patient-specific factors like renal/hepatic function and comorbidities as detailed above.


## **Side Effects**


### **Common Side Effects**

* Drowsiness
* Dizziness
* Diarrhea
* Restlessness


### **Rare but Serious Side Effects**

* Extrapyramidal reactions (dystonia, akathisia, tardive dyskinesia)
* Neuroleptic malignant syndrome
* Hypersensitivity reactions


### **Long-Term Effects**

Tardive dyskinesia is a potential long-term effect associated with prolonged metoclopramide use.


### **Adverse Drug Reactions (ADR)**

Extrapyramidal symptoms and hypersensitivity reactions are potentially serious ADRs.


## **Contraindications**

* Hypersensitivity to paracetamol or metoclopramide
* Gastrointestinal obstruction, hemorrhage, or perforation
* Pheochromocytoma
* Epilepsy or seizure disorders (caution)
* Parkinson's disease


## **Drug Interactions**

* Anticholinergic drugs
* CNS depressants (alcohol, opioids, sedatives)
* Levodopa
* Digoxin

## **Pregnancy and Breastfeeding**

Metoclopramide crosses the placenta and is present in breast milk.  While generally considered safe during pregnancy and breastfeeding, it's best to use it only when clearly needed and at the lowest effective dose for the shortest duration.  Consult with a specialist to assess the benefit-risk ratio for each individual patient.


## **Drug Profile Summary**

* **Mechanism of Action:**  Paracetamol: Central prostaglandin inhibition; Metoclopramide: Dopamine D2 antagonist, 5-HT3 antagonist, 5-HT4 agonist.
* **Side Effects:** Drowsiness, dizziness, extrapyramidal symptoms (rare but serious).
* **Contraindications:** Hypersensitivity, GI obstruction, pheochromocytoma.
* **Drug Interactions:**  CNS depressants, levodopa, anticholinergics.
* **Pregnancy & Breastfeeding:**  Generally safe but use with caution.
* **Dosage:** Adults: Two tablets initially, then one or two every four hours as needed, not exceeding six tablets/24 hours.
* **Monitoring Parameters:** Observe for extrapyramidal symptoms, especially in children and young adults.


## **Popular Combinations**

This particular combination of paracetamol and metoclopramide is already a commonly used formulation.  However, in clinical practice, metoclopramide can be combined with other antiemetics like 5-HT3 antagonists (e.g., ondansetron) in cases of severe nausea and vomiting.


## **Precautions**

As above.



## **FAQs (Frequently Asked Questions)**

### **Q1: What is the recommended dosage for Metoclopramide + Paracetamol?**
**A:** The standard adult dosage is two tablets initially, then one or two every four hours as needed, not exceeding six tablets in 24 hours.

### **Q2: What are the common side effects?**
**A:** Common side effects include drowsiness, dizziness, diarrhea, and restlessness.

### **Q3:  Is this combination safe in pregnancy?**
**A:** Although generally considered safe, it should be used with caution during pregnancy, after careful assessment of the benefit-risk ratio.

### **Q4: Are there any serious side effects to be aware of?**
**A:**  Rare but serious side effects include extrapyramidal reactions (dystonia, akathisia, tardive dyskinesia), neuroleptic malignant syndrome, and hypersensitivity reactions.

### **Q5:  Can this medication be used in children?**
**A:**  It's generally not recommended for children under 12. Consult specialized pediatric resources for specific cases.

### **Q6: What are the contraindications for this combination?**
**A:** Contraindications include hypersensitivity, GI obstruction, hemorrhage, perforation, and pheochromocytoma.

### **Q7: What should I monitor patients for when prescribing this medication?**
**A:** Monitor patients for extrapyramidal symptoms, particularly in children, young adults, and patients receiving higher doses.

### **Q8: How does metoclopramide work in migraine?**
**A:**  Metoclopramide is thought to relieve migraine-associated nausea and vomiting by blocking dopamine receptors in the chemoreceptor trigger zone and enhancing gastric emptying.  It also has some analgesic properties through its effects on serotonin receptors.

### **Q9: What are the alternatives if this combination is not suitable?**
**A:**  Alternative treatments for migraine might include other antiemetics (e.g., ondansetron), NSAIDs or triptans for pain, or other combination therapies.  The choice depends on the specific patient's presentation and medical history.

